Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci.

Raney PM, Tenover FC, Carey RB, McGowan JE Jr, Patel JB.

Diagn Microbiol Infect Dis. 2006 Jul;55(3):213-8. Epub 2006 Mar 20.

PMID:
16545937
2.

Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus.

Steward CD, Raney PM, Morrell AK, Williams PP, McDougal LK, Jevitt L, McGowan JE Jr, Tenover FC.

J Clin Microbiol. 2005 Apr;43(4):1716-21.

5.

Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae.

Schwaber MJ, Raney PM, Rasheed JK, Biddle JW, Williams P, McGowan JE Jr, Tenover FC.

J Clin Microbiol. 2004 Jan;42(1):294-8.

6.

Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE.

Tenover FC, Raney PM, Williams PP, Rasheed JK, Biddle JW, Oliver A, Fridkin SK, Jevitt L, McGowan JE Jr; Project ICARE.

J Clin Microbiol. 2003 Jul;41(7):3142-6.

7.

Validation of Vitek version 7.01 software for testing staphylococci against vancomycin.

Raney PM, Williams PP, McGowan JE, Tenover FC.

Diagn Microbiol Infect Dis. 2002 Jun;43(2):135-40.

PMID:
12088621
8.

Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.

Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, Williams PP, Brittain KL, Oliver A, McGowan JE Jr, Tenover FC.

J Clin Microbiol. 2001 Aug;39(8):2864-72.

9.

In vitro activity of A-192411.29, a novel antifungal lipopeptide.

Nilius AM, Raney PM, Hensey-Rudloff DM, Wang W, Li Q, Flamm RK.

Antimicrob Agents Chemother. 2000 May;44(5):1242-6.

10.

Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.

Griesgraber G, Kramer MJ, Elliott RL, Nilius AM, Ewing PJ, Raney PM, Bui MH, Flamm RK, Chu DT, Plattner JJ, Or YS.

J Med Chem. 1998 May 7;41(10):1660-70.

PMID:
9572891
11.

Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.

Elliott RL, Pireh D, Griesgraber G, Nilius AM, Ewing PJ, Bui MH, Raney PM, Flamm RK, Kim K, Henry RF, Chu DT, Plattner JJ, Or YS.

J Med Chem. 1998 May 7;41(10):1651-9.

PMID:
9572890

Supplemental Content

Loading ...
Support Center